We assessed associations between LUS and four clinical metrics: provider-assessed volume status, > 30% NT-proBNP increase, > 5 lb weight gain, and PAD above goal (CardioMEMS).<h4>Results</h4>Seventy-five subjects were enrolled. The gene discussed is NPPB; the disease is peripheral arterial disease.